Biased agonism at adenosine receptors.

Cardiovascular Diseases / metabolism Drug Discovery Humans Ligands Neoplasms / metabolism Parkinson Disease / metabolism Receptors, Purinergic P1 / metabolism Structure-Activity Relationship
Adenosine receptor Allostery Biased agonism Drug discovery G protein-coupled receptor

Journal

Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683

Informations de publication

Date de publication:
06 2021
Historique:
received: 10 11 2020
revised: 11 02 2021
accepted: 13 02 2021
pubmed: 22 2 2021
medline: 18 1 2022
entrez: 21 2 2021
Statut: ppublish

Résumé

Adenosine modulates many aspects of human physiology and pathophysiology through binding to the adenosine family of G protein-coupled receptors, which are comprised of four subtypes, the A

Identifiants

DOI: 10.1016/j.cellsig.2021.109954 PMID: 33610717
pubmed: 33610717
pii: S0898-6568(21)00042-5
doi: 10.1016/j.cellsig.2021.109954
pii:
doi:

Substances chimiques

Ligands 0
Receptors, Purinergic P1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109954

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Samantha M McNeill (SM)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Jo-Anne Baltos (JA)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; Department of Pharmacology, Monash University, Melbourne, VIC, Australia. Electronic address: joanne.baltos@monash.edu.

Paul J White (PJ)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Lauren T May (LT)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; Department of Pharmacology, Monash University, Melbourne, VIC, Australia. Electronic address: lauren.may@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies cardiovasculaires › Biased agonism at adenosine receptors.
questionsmedicales.fr › Techniques d'investigation › Développement de médicament › Découverte de médicament › Biased agonism at adenosine receptors.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Biased agonism at adenosine receptors.
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Ligands › Biased agonism at adenosine receptors.
questionsmedicales.fr › Tumeurs › Biased agonism at adenosine receptors.
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Biased agonism at adenosine receptors.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs purinergiques › Récepteurs purinergiques P1 › Biased agonism at adenosine receptors.
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Biased agonism at adenosine receptors.